Streetbeat News

Stock Prices

MSFT

SNPS

Synopsys Inc (NASDAQ:SNPS) is set to report Q4 earnings with expectations of $3.03 EPS and $1.58 billion in revenue. The stock has risen 70% YTD and saw a 2.5%+ increase after announcing a strategic collaboration with Microsoft Inc (NASDAQ:MSFT) involving Synopsys.ai Copilot and Azure OpenAI Service. Analysts focus on Synopsys' AI integration in EDA, demand for AI chips, and internal workflow optimization. The company has a Buy consensus rating with a $405.23 target price, while Stifel's Ruben Roy has a $550 target, citing robust semiconductor design activity and progress on AI tools.

Portfolio Pulse from Surbhi Jain

November 29, 2023 | 3:23 pm

SPY

Federal Reserve Bank of Richmond President Thomas Barkin stated that achieving a 2% inflation target is very achievable. He did not provide a specific timeline or policy measures to reach this goal. The statement may influence investor expectations regarding interest rate policies and economic stability.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:23 pm

UBER

Uber Technologies, Inc. plans to integrate London's black cabs into its platform in 2024, despite opposition from the Licensed Taxi Drivers Association (LTDA). The service will offer commission-free bookings for the first six months. LTDA criticized Uber's safety record, but Uber cites successful taxi integrations in other cities. The first black cab driver to join Uber sees potential for increased earnings. Uber's Q3 FY23 revenue grew 11% to $9.29 billion, missing estimates, with trips up 25% year-over-year.

Portfolio Pulse from Anusuya Lahiri

November 29, 2023 | 3:23 pm

EQT

Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on EQT Corporation (NYSE:EQT) and increased the price target from $38 to $39.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:22 pm

EWY

SPY

USO

The U.S. has imposed additional sanctions related to Iran and North Korea, potentially affecting global markets and certain sectors. While specific companies are not targeted, ETFs like EWY, SPY, and USO may experience indirect impacts due to changes in market sentiment and geopolitical tensions.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:21 pm

EOG

Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on EOG Resources (NYSE:EOG) and increased the price target from $132 to $134.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:20 pm

AMZN

ASML

NVDA

TSM

Nvidia Corp (NVDA) sees its stock rise as it strengthens its partnership with Amazon Web Services (AMZN) for new AI chips and collaborates with Chinese expertise for autonomous vehicles. Nvidia, along with Taiwan Semiconductor Manufacturing Co (TSM), leads the advanced chip market, posing a challenge to competitors like OpenAI. Nvidia dominates the GPU market, crucial for machine learning, while TSMC leads in advanced chip production. Both companies face manufacturing and patent challenges, but Nvidia is adapting its AI chips to comply with U.S. regulations for the China market. NVDA stock has surged over 234% YTD.

Portfolio Pulse from Anusuya Lahiri

November 29, 2023 | 3:19 pm

LLY

NVO

Lebanese health officials reported 11 cases of severe hypoglycemia due to suspected counterfeit Ozempic, a diabetes medication by Novo Nordisk (NVO). The fake drugs had incorrect dosages, and the issue is part of a global rise in counterfeit products, with at least 17 countries affected. Novo Nordisk is working with local authorities to address the issue. NVO shares dropped slightly by 0.14%.

Portfolio Pulse from Vandana Singh

November 29, 2023 | 3:17 pm

VVOS

Vivos Therapeutics Inc (NASDAQ:VVOS) received FDA 510(k) clearance for its CARE oral appliances to treat severe obstructive sleep apnea (OSA) in adults. This makes Vivos the first company to offer an alternative to CPAP or surgical neurostimulation implants for severe OSA patients. The approval follows previous clearance for treating mild-to-moderate OSA. Data showed significant improvement in 80% of severe OSA patients with an average treatment time of 9.7 months. VVOS stock surged 169.70% to $11.84.

Portfolio Pulse from Vandana Singh

November 29, 2023 | 3:15 pm

CRWD

Morgan Stanley analyst Hamza Fodderwala has maintained an Equal-Weight rating on CrowdStrike Holdings (CRWD) and increased the price target from $187 to $203.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:13 pm